Is D2 lymphadenectomy for gastric cancer a staging tool or a therapeutic intervention?

Surgical Oncology Clinics of North America

Volumn 11, Issue 2, 2002, Pages 415-430

  Spanknebel, Kathryn A ^a   Brennan, Murray F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INVASION; CANCER STAGING; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PATIENT COMPLIANCE; PROGNOSIS; QUALITY CONTROL; REVIEW; STOMACH CANCER; MORTALITY; PATHOLOGY; STOMACH TUMOR; TREATMENT OUTCOME;

HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; TREATMENT OUTCOME; HUMANS;

EID: 0036544965     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(02)00008-X     Document Type: Review

References (76)

1. Early results of extended total gastrectomy for cancer
2. Extended surgery for gastric cancer: An historical commentary
3. Extended lymph-node dissection for gastric cancer
4. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial
5. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification
6. TNM classification of malignant tumors
7. Pancreas-preserving total gastrectomy for proximal gastric cancer
8. No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer
9. Lymph node metastases of gastric cancer. General pattern in 1931 patients
10. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer
11. Prognostic factors in gastric cancer with serosal invasion. Univariate and multivariate analyses
12. Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathologic and treatment factors
13. Lymph node staging in gastric cancer: Is location more important than number? An analysis of 1,038 patients
14. Results of surgery correlated with staging
15. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer
16. Rate of detection of lymph node metastasis is correlated with the depth of submucosal invasion in early stage gastric cancer
17. Surgical treatment of gastric cancer with special reference to lymph node removal
18. Radical surgery for gastric cancer. A review of the Japanese experience
19. Ignoring small lymph nodes can be a major cause of staging error in gastric cancer
20. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma
21. Is the new UICC staging system of gastric cancer reasonable? (Comparison of 5-year survival rate of gastric cancer by old and new UICC stage classification)
22. Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer
23. Prognostic significance of the number of positive lymph nodes in gastric carcinoma
24. Perigastric lymph node status as a prognostic indicator in patients with gastric cancer
25. Classification of regional lymph node metastasis from gastric carcinoma
26. The number of metastatic lymph nodes: A promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification
27. Evaluation of the new AJCC/UICC classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification
28. Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery
29. Lymph node metastases in gastric cancer invading the submucosal layer
30. Conditions where gastric carcinomas with submucosal invasion have no lymph node metastasis: Radical cure of gastric carcinomas with submucosal invasion by endoscopic mucosal resection
31. Degree of submucosal invasion of early gastric carcinoma and risk for lymph node metastasis: Consideration limiting applicability for endscopic resection
32. Endoscopic resection for early gastric cancer: The actual procedure and clinical evaluation
33. Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system
34. Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer
35. Is lymphadenectomy necessary for early gastric cancer?
36. The management of early gastric cancer
37. Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer
38. Comparison of the conventional method of lymph node staging with a comprehensive fat-clearing method for gastric adenocarcinoma
39. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases
40. Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients
41. Immunohistochemical detection of lymph node microinvolvement in node-negative gastric cancer
42. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence
43. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinoma
44. Clinicopathological value of immunohistochemical detection of occult involvement on pT3N0 gastric cancer
45. Lymph node micrometastases in patients with early gastric cancer: Experience with 139 patients
46. Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer
47. Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer
48. Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer
49. Progress in gastric cancer surgery in Japan and its limits of radicality
50. Prognostic significance and surgical management of lymph node metastasis in gastric cancer
51. A patient care study by the American College of Surgeons
52. Prognostic relevance of systematic lymph node dissection in gastric carcinoma
53. The National Cancer Database report on gastric carcinoma
54. Surgery for gastric cancer: The American view
55. Extensive versus limited lymph node dissection for gastric cancer: A comparative study of 320 patients
56. Prognostic importance of radical lymphadenectomy in curative resections for gastric cancer
57. Prognostic significance of lymph node dissection in gastric cancer
58. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan
59. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma
60. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: A prospective long-term follow-up study
61. Lymph node staging in 872 patients with carcinoma of the stomach and the presumed benefit of lymphadenectomy
62. Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study
63. The Turkish experience with curative gastrectomies for gastric carcinoma: Is D2 dissection worthwhile?
64. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer
65. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma
66. Controlled trials and the R1/R2 controversy in the management of gastric carcinoma
67. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer
68. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial
69. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients
70. R2 compared with R1 resection for gastric cancer: Morbidity and mortality in a prospective, randomised trial
71. Lymph-node dissection for gastric cancer
72. Factors influencing noncompliance and contamination in a randomized trial of "Western" (r1) versus "Japanese" (R2) type surgery in gastric cancer
73. Evaluation of the extent of lymphadenectomy in a randomized trial of Western-versus Japanese-type surgery in gastric cancer
74. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial
75. Surgery for gastric cancer